Department of Internal Medicine, Bozyaka Training and Research Hospital, Izmir, Turkey.
Rheumatol Int. 2013 Aug;33(8):1967-72. doi: 10.1007/s00296-013-2681-8. Epub 2013 Jan 29.
The aim of this was to evaluate some of the vascular biomarkers and cytokines related with atherosclerosis in regularly treated and attack-free familial Mediterranean fever (FMF) patients. Forty (21 males [M] and 19 females [F], 31 [15-58] years) FMF patients and eighteen healthy controls (11 M and 7 F, 35.5 [19-46] years) with no known cardiovascular (CV) risk factors were included. All patients were receiving regular colchicine treatment, and examinations were performed during attack-free periods. Serum samples were used for the determination of high-sensitive C-reactive protein (hs-CRP), tissue factor (TF), tissue plasminogen activator (t-PA), osteoprotegerin (OPG), interleukin-6 (IL-6), IL-17, and IL-23. Plasma samples were used for the determination of asymmetric dimethylarginine (ADMA) and thrombomodulin (TM). Age, sex distribution, waist circumference, body mass index, smoking status, and serum lipids were similar between the patients and controls (P > 0.05). The concentrations of (hs-CRP) and IL-17 were significantly higher in FMF patients compared with controls (P < 0.05). On the other hand, IL-6 and IL-23 levels were not different between the groups (P > 0.05). ADMA, OPG, and TM concentrations were significantly lower in the patients' group compared to those of controls (P < 0.05). However, vWF, TF, and t-PA levels were similar between the groups (P > 0.05). FMF patients receiving regular colchicine therapy during inactive disease state had significantly lower levels of vascular injury parameters.
本研究旨在评估一些与动脉粥样硬化相关的血管生物标志物和细胞因子在常规治疗且无发作的家族性地中海热(FMF)患者中的变化。共纳入 40 例(21 名男性[M]和 19 名女性[F],年龄 31[15-58]岁)FMF 患者和 18 名健康对照者(11 名男性和 7 名女性,年龄 35.5[19-46]岁),这些对照者均无已知的心血管(CV)危险因素。所有患者均接受常规秋水仙碱治疗,且检查均在无发作期间进行。采集血清样本用于测定高敏 C 反应蛋白(hs-CRP)、组织因子(TF)、组织型纤溶酶原激活物(t-PA)、护骨素(OPG)、白细胞介素-6(IL-6)、白细胞介素-17(IL-17)和白细胞介素-23(IL-23)。采集血浆样本用于测定不对称二甲基精氨酸(ADMA)和血栓调节蛋白(TM)。患者与对照组间年龄、性别分布、腰围、体重指数、吸烟状态和血清脂质水平均相似(P>0.05)。与对照组相比,FMF 患者的 hs-CRP 和 IL-17 浓度明显更高(P<0.05)。另一方面,两组间 IL-6 和 IL-23 水平无差异(P>0.05)。与对照组相比,患者组的 ADMA、OPG 和 TM 浓度明显更低(P<0.05)。然而,两组间 vWF、TF 和 t-PA 水平相似(P>0.05)。在无疾病活动期接受常规秋水仙碱治疗的 FMF 患者的血管损伤参数水平显著降低。